HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypoxia up-regulates the angiogenic cytokine secretoneurin via an HIF-1alpha- and basic FGF-dependent pathway in muscle cells.

Abstract
Expression of angiogenic cytokines like vascular endothelial growth factor is enhanced by hypoxia. We tested the hypothesis that decreased oxygen levels up-regulate the angiogenic factor secretoneurin. In vivo, muscle cells of mouse ischemic hind limbs showed increased secretoneurin expression, and inhibition of secretoneurin by a neutralizing antibody impaired the angiogenic response in this ischemia model. In a mouse soft tissue model of hypoxia, secretoneurin was increased in subcutaneous muscle fibers. In vitro, secretoneurin mRNA and protein were up-regulated in L6 myoblast cells after exposure to low oxygen levels. The hypoxia-dependent regulation of secretoneurin was tissue specific and was not observed in endothelial cells, vascular smooth muscle cells, or AtT20 pituitary tumor cells. The hypoxia-dependent induction of secretoneurin in L6 myoblasts is regulated by hypoxia-inducible factor-1alpha, since inhibition of this factor using si-RNA inhibited up-regulation of secretoneurin. Induction of secretoneurin by hypoxia was dependent on basic fibroblast growth factor in vivo and in vitro, and inhibition of this regulation by heparinase suggests an involvement of low-affinity basic fibroblast growth factor binding sites. In summary, our data show that the angiogenic cytokine secretoneurin is up-regulated by hypoxia in muscle cells by hypoxia-inducible factor-1alpha- and basic fibroblast growth factor-dependent mechanisms.
AuthorsMargot Egger, Wilfried Schgoer, Arno G E Beer, Johannes Jeschke, Johannes Leierer, Markus Theurl, Silke Frauscher, Oren M Tepper, Andreas Niederwanger, Andreas Ritsch, Marianne Kearney, Julia Wanschitz, Geoffrey C Gurtner, Reiner Fischer-Colbrie, Guenter Weiss, Hildegunde Piza-Katzer, Douglas W Losordo, Josef R Patsch, Peter Schratzberger, Rudolf Kirchmair
JournalFASEB journal : official publication of the Federation of American Societies for Experimental Biology (FASEB J) Vol. 21 Issue 11 Pg. 2906-17 (Sep 2007) ISSN: 1530-6860 [Electronic] United States
PMID17504977 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA Primers
  • Hif1a protein, mouse
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Neuropeptides
  • RNA, Small Interfering
  • Secretogranin II
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • NAD
  • Fibroblast Growth Factor 2
  • secretoneurin
  • Pcsk6 protein, mouse
  • Proprotein Convertases
Topics
  • Animals
  • Blotting, Western
  • Cell Hypoxia
  • Cells, Cultured
  • DNA Primers (chemistry)
  • Endothelium, Vascular (cytology, metabolism)
  • Extremities (surgery)
  • Fibroblast Growth Factor 2 (metabolism)
  • Fluorescent Antibody Technique
  • Hypoxia-Inducible Factor 1, alpha Subunit (metabolism)
  • Ischemia (metabolism, pathology)
  • Mice
  • Mice, Inbred C57BL
  • Muscle, Smooth, Vascular (blood supply, cytology, metabolism)
  • Myoblasts (metabolism)
  • NAD (metabolism)
  • Neovascularization, Physiologic
  • Neuropeptides (metabolism)
  • Pituitary Neoplasms (blood supply, metabolism, pathology)
  • Polymerase Chain Reaction
  • Proprotein Convertases (metabolism)
  • RNA, Small Interfering (pharmacology)
  • Radioimmunoassay
  • Rats
  • Secretogranin II (metabolism)
  • Signal Transduction
  • Skin (metabolism)
  • Transfection
  • Vascular Endothelial Growth Factor A (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: